Cognition Therapeutics, Inc.

📍 Purchase, United States🗓 Founded 2007👥 33 employees💰 Last funded Jan 2017
Biotechnology Research🌐 cogrx.com
Website LinkedIn
Cognition Therapeutics, Inc. is a clinical stage neuroscience company developing drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders.
3
Total investors
0
Early stage
0
Mid stage
2
Late stage
2007
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2015–2017 · investors recorded per year
201512016120171
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Cognition Therapeutics, Inc.?
Cognition Therapeutics, Inc. has 3 investors on record on gritt.io and 2 late-stage investors.
When did Cognition Therapeutics, Inc. last raise funding?
The most recent investment in Cognition Therapeutics, Inc. recorded on gritt.io was in January 2017.
When was Cognition Therapeutics, Inc. founded?
Cognition Therapeutics, Inc. was founded in 2007.
What industry is Cognition Therapeutics, Inc. in?
Cognition Therapeutics, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Cognition Therapeutics, Inc. based?
Cognition Therapeutics, Inc. is headquartered in Purchase, United States.